{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:06:29Z","timestamp":1772165189615,"version":"3.50.1"},"reference-count":43,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Therapeutic advancements utilizing modulators of the cystic fibrosis transmembrane conductance regulator (CFTR) have revolutionized the treatment of people with cystic fibrosis (pwCF). Elexacaftor-Tezacaftor-Ivacaftor (ETI) is a highly effective modulator therapy and has been shown to improve health outcomes in people with CF (PwCF). Due to these therapeutic advancements, many pwCF are getting older, but little is known regarding the safety and efficacy of ETI in pwCF at a more advanced age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We aimed to determine the effect of ETI on clinical outcomes in older pwCF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This study was a single-center, retrospective analysis of pwCF who received open-label ETI following FDA approval and were over the age of 40 at the time of ETI initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Data were obtained from the electronic medical record from a large CF center in the United States of America between November 2019 and January 2021, including body mass index (BMI), lung function as % predicted FEV\n                      <jats:sub>1<\/jats:sub>\n                      before ETI initiation, and approximately 3\u2009months and one a follow-up visit within 9\u201315\u2009months post-ETI initiation. The exacerbation frequency over 12\u2009months was recorded before and after ETI initiation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty-two patients met the inclusion criteria. Mean age at time of ETI initiation was 47.9, 23 patients (54.8%) were male, and 11 (26.2%) were homozygous for the F508del mutation. Linear mixed effects models suggest a monthly increase of 0.24 (95% CI 0.08\u20130.41,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003) for ppFEV1 and 0.03 (95% CI 0.002\u20130.06,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.036) for BMI post-ETI, resulting in a 2.96 (95% CI 0.98\u20134.95) increase in ppFEV1 and 0.39 (95% CI 0.03\u20130.76) increase in BMI approximately 1-year post-ETI. In addition, a significant decline in pulmonary exacerbations was seen in the year following ETI initiation (1.5\u2009\u00b1\u20091.3 exacerbations\/year prior vs 0.5\u2009\u00b1\u20090.7 exacerbations\/year post;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Treatment with ETI in this unique cohort of pwCF was safe. Whereas ETI affected BMI in a subtle way, initiation of ETI was associated with stabilization of lung disease with a significant but moderate increase in lung function and a decline in the number of exacerbations in the follow-up period. Longer and larger studies will be needed to analyze the effect of ETI on an aging CF population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17534666251410246","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:25:43Z","timestamp":1767417943000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of \u201caged\u201d people with cystic fibrosis"],"prefix":"10.1177","volume":"20","author":[{"given":"Sydney","family":"Blankenship","sequence":"first","affiliation":[{"name":"Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin V.","family":"Flueckiger","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godsgift","family":"Caleb","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-4782","authenticated-orcid":false,"given":"Julianna","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Krick","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, THT422, 1900 University Boulevard, Birmingham, AL 35294, USA"},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00576-6"},{"issue":"6","key":"e_1_3_5_3_2","first-page":"584","article-title":"Cystic fibrosis: current concepts","volume":"78","author":"Lopez-Valdez JA","year":"2021","unstructured":"Lopez-Valdez JA, Aguilar-Alonso LA, Gandara-Quezada V, et al. Cystic fibrosis: current concepts. Bol Med Hosp Infant Mex 2021; 78(6): 584\u2013596.","journal-title":"Bol Med Hosp Infant Mex"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2216474"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23280"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25627"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060458"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade2216"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01662"},{"issue":"7","key":"e_1_3_5_10_2","article-title":"A review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy","volume":"13","author":"Zaher A","year":"2021","unstructured":"Zaher A, ElSaygh J, Elsori D, et al. A review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. Cureus 2021; 13(7): e16144.","journal-title":"Cureus"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1986OC"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1855980"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100690"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01241-2023"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1697975"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_3_5_18_2","volume-title":"Applied longitudinal data analysis: modeling change and event occurence","author":"Judith D","year":"2003","unstructured":"Judith D, Singer JBW. Applied longitudinal data analysis: modeling change and event occurence. Oxford University Press, 2003."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0005"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.02.006"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.04.010"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114511005460"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2015-0271"},{"key":"e_1_3_5_24_2","first-page":"100276","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney KA","year":"2021","unstructured":"Kutney KA, Sandouk Z, Desimone M, et al. Obesity in cystic fibrosis. J Clin Transl Endocrinol 2021; 26: 100276.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.015"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chpulm.2024.100099"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167957"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03148-21"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00787-24"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23288"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241254090"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201907-493OC"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.08.002"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01008-2023"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26261"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.11.003"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02630-z"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1737.172297"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184171"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.10.014"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009235"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00509-2020"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00364.2016"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42404-6"}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251410246","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17534666251410246","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251410246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:35:37Z","timestamp":1769362537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17534666251410246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["10.1177\/17534666251410246"],"URL":"https:\/\/doi.org\/10.1177\/17534666251410246","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/17534666251410246\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v4\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v4\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v4\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251410246\/v3\/decision1","asserted-by":"object"}]},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"17534666251410246"}}